We observed hypermethylation (promoter CGI methylation >0.2) of the TET2 promoter in 26% of patients with T-ALL, resulting in a decrease or complete loss of TET2 expression and coinciding with high overall CGI methylation (Fig. 6b and Extended Data Fig. 6b,c). The gene discussed is TET2; the disease is acute lymphoblastic leukemia.